146 related articles for article (PubMed ID: 37146246)
1. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda K; Yanagiya R; Miyatake Y; Carreras J; Higuchi H; Murayama H; Ishida T; Ito A; Iida S; Fukuhara N; Harigae H; Fujioka Y; Takahashi N; Wada H; Ishida F; Nakazawa H; Ishihara R; Murakami Y; Tagawa H; Matsuura T; Nakagawa S; Iwabuchi S; Hashimoto S; Imadome KI; Nakamura N; Ishizawa K; Kanda Y; Ando K; Kotani A
Blood; 2023 Jul; 142(4):352-364. PubMed ID: 37146246
[TBL] [Abstract][Full Text] [Related]
2. A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.
Sugimoto KJ; Shimada A; Wakabayashi M; Imai H; Sekiguchi Y; Nakamura N; Sawada T; Ota Y; Takeuchi K; Ito Y; Kimura H; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(1):411-7. PubMed ID: 24427365
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
4. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
Haji S; Shiratsuchi M; Matsushima T; Takamatsu A; Tsuda M; Tsukamoto Y; Tanaka E; Ohno H; Fujioka E; Ishikawa Y; Imadome KI; Ogawa Y
Int J Hematol; 2017 Apr; 105(4):540-544. PubMed ID: 27830541
[TBL] [Abstract][Full Text] [Related]
5. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?
Ko YH; Park S; Kim K; Kim SJ; Kim WS
Acta Haematol; 2008; 120(4):199-206. PubMed ID: 19153474
[TBL] [Abstract][Full Text] [Related]
6. Targeting iron import to treat ANKL.
Gotthardt D
Blood; 2023 Jul; 142(4):308-309. PubMed ID: 37498584
[No Abstract] [Full Text] [Related]
7. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
Park JA; Jun KR; Nam SH; Ghim TT
Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
You E; Park CJ; Lee MY; Cho YU; Jang S; Lee JH; Lee JH; Lee KH
Int J Med Sci; 2023; 20(2):206-210. PubMed ID: 36794163
[TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
Kim BK; Hong KT; Kang HJ; An HY; Choi JY; Hong CR; Park KD; Lee DS; Shin HY
J Pediatr Hematol Oncol; 2019 Jul; 41(5):e336-e337. PubMed ID: 29889803
[TBL] [Abstract][Full Text] [Related]
10. Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker.
Yoo EH; Kim HJ; Lee ST; Kim WS; Kim SH
Korean J Lab Med; 2009 Dec; 29(6):491-6. PubMed ID: 20046078
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites.
Gao LM; Zhao S; Liu WP; Zhang WY; Li GD; Küçük C; Hu XZ; Chan WC; Tang Y; Ding WS; Yan JQ; Yao WQ; Wang JC
Am J Surg Pathol; 2016 Jun; 40(6):836-46. PubMed ID: 26975038
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous Hepatic Rupture Associated With Epstein-Barr Virus Negative Aggressive Natural Killer Cell Leukemia.
Can NT; Bissonnette ML; Mirza MK; Hart J; Te H; Churpek JE
World J Oncol; 2014 Dec; 5(5-6):210-213. PubMed ID: 29147405
[TBL] [Abstract][Full Text] [Related]
13. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
[TBL] [Abstract][Full Text] [Related]
14. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.
Yamashita Y; Nishikawa A; Iwahashi Y; Fujimoto M; Sasaki I; Mishima H; Kinoshita A; Hemmi H; Kanazawa N; Ohshima K; Imadome KI; Murata SI; Yoshiura KI; Kaisho T; Sonoki T; Tamura S
Int J Hematol; 2019 Jun; 109(6):744-750. PubMed ID: 30706328
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and Pathological Characteristics of Aggressive Natural Killer Cell Leukemia Patients].
Wang LP; Yu YP; Mei JG; Song P; An ZM; Zhou XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1093-1100. PubMed ID: 34362487
[TBL] [Abstract][Full Text] [Related]
17. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
[TBL] [Abstract][Full Text] [Related]
18. Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.
Huang L; Liu D; Wang N; Ling S; Tang Y; Wu J; Hao L; Luo H; Hu X; Sheng L; Zhu L; Wang D; Luo Y; Shang Z; Xiao M; Mao X; Zhou K; Cao L; Dong L; Zheng X; Sui P; He J; Mo S; Yan J; Ao Q; Qiu L; Zhou H; Liu Q; Zhang H; Li J; Jin J; Fu L; Zhao W; Chen J; Du X; Qing G; Liu H; Liu X; Huang G; Ma D; Zhou J; Wang QF
Cell Res; 2018 Feb; 28(2):172-186. PubMed ID: 29148541
[TBL] [Abstract][Full Text] [Related]
19. Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia.
Li C; Tian Y; Wang J; Zhu L; Huang L; Wang N; Xu D; Cao Y; Li J; Zhou J
Transl Res; 2014 Jun; 163(6):565-77. PubMed ID: 24524877
[TBL] [Abstract][Full Text] [Related]
20. Long term survival in aggressive NK cell leukemia.
Patel AP; Ghatak SB; Patel JA
Indian Pediatr; 2010 Sep; 47(9):807-8. PubMed ID: 21048272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
